Medication days' supply, Adherence, wastage, and cost among chronic patients in Medicaid

Medicare and Medicaid Research Review

Volumn 2, Issue 3, 2012, Pages

  Taitel, Michael ^a   Fensterheim, Leonard ^a   Kirkham, Heather ^a   Sekula, Ryan ^a   Duncan, Ian ^a  

^a Walgreens Clinical Outcomes and Analytics   (United States)

Author keywords

Adherence; Day Supply; Drug Utilization; Medicaid; Medication Wastage; Pharmacy; Un used Medication

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; PRESCRIPTION DRUG;

ARTICLE; CHRONIC PATIENT; DRUG COST; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL RECORD REVIEW; MEDICATION SUPPLY; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; RETROSPECTIVE STUDY; ADULT; CALIFORNIA; CHRONIC DISEASE; COST CONTROL; ECONOMICS; EPIDEMIOLOGY; FEMALE; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UNITED STATES;

ADULT; CALIFORNIA; CHRONIC DISEASE; COST SAVINGS; FEMALE; HUMANS; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84930484162     PISSN: 21590354     EISSN: None     Source Type: Journal    
DOI: 10.5600/mmrr.002.03.a04     Document Type: Article

References (23)

1. Bagchi, A. D., Verdier, J., & Esposito, D. (2011). Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2007. Retrieved from http://www.cms.gov/MedicaidDataSourcesGenInfo/downloads/Pharmacy_Rx_Chartbook_2007.pdf.
2. Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: terminology and definitions. Value in Health, 11(1), 44-47. PubMed http://dx.doi.org/10.1111/j.1524-4733.2007.00213.x
3. Daughton, C. G. (2010). Drugs and the Environment: Stewardship & Sustainability. National Exposure Research Laboratory, Environmental Sciences Division, US EPA.
4. Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012). How patient cost-sharing trends affect adherence and outcomes: a literature review. P & T: A Peer Reviewed Journal for Formulary Management, 37(1), 45-55.
5. Farley, J. F., Harley, C. R., & Devine, J. W. (2006). A comparison of comorbidity measurements to predict healthcare expenditures. The American Journal of Managed Care, 12(2), 110-119. PubMed
6. Frank, R. G. (2001). Prescription drug prices: why do some pay more than others do? Health Affairs (Project Hope), 20(2), 115-128. doi: PubMed http://dx.doi.org/10.1377/hlthaff.20.2.115
7. Gagne, J. J., Polinski, J. M., Avorn, J., Glynn, R. J., & Seeger, J. D. (2012). Standards for Causal Inference Methods in Analyses of Data from Observational and Experimental Studies in Patient-Centered Outcomes Research. Washington, DC: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School.
8. Kronick, R. G., Bella, M., & Gilmer, T. P. (2009). The faces of Medicaid III: Refining the portrait of people with multiple chronic conditions Center for Health Care Strategies, Inc.
9. Landon, B. E., Tobias, C., & Epstein, A. M. (1998). Quality management by state Medicaid agencies converting to managed care. [doi:]. Journal of the American Medical Association, 279(3), 211-216. PubMed http://dx.doi.org/10.1001/jama.279.3.211
10. Motheral, B. (2011). 2011-2012 Prescription Drug Benefit Cost and Plan Design Report: Pharmacy Benefit Management Institute.
11. National Pharmaceutical Council (2007). Pharmaceutical Benefits Under State Medical Assistance Programs. Retrieved from: http://www.npcnow.org/Public/Research_Publications/Publications/pub_rel_research/pub_medicaid/Pharmaceutical_Benefits_Under_State_Medical_Assistance_Programs_2007.aspx
12. Nichol, M. B., Knight, T. K., Priest, J. L., Wu, J., & Cantrell, C. R. (2010). Nonadherence to clinical practice guidelines and medications for multiple chronic conditions in a California Medicaid population. Journal of the American Pharmacists Association, 50(4), 496-507. doi: PubMed http://dx.doi.org/10.1331/JAPhA.2010.09123
13. Opolka, J. L., Rascati, K. L., Brown, C. M., & Gibson, P. J. (2003). Role of ethnicity in predicting antipsychotic medication adherence. The Annals of Pharmacotherapy, 37(5), 625-630. PubMed http://dx.doi.org/10.1345/aph.1C321
14. Paterson, J. M., & Anderson, G. M. (2002). "Trial" prescriptions to reduce drug wastage: results from Canadian programs and a community demonstration project. The American Journal of Managed Care, 8(2), 151-158. PubMed
15. Raven, M. C., Billings, J. C., Goldfrank, L. R., Manheimer, E. D., & Gourevitch, M. N. (2009). Medicaid patients at high risk for frequent hospital admission: real-time identification and remediable risks. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 86(2), 230-241. doi: PubMed http://dx.doi.org/10.1007/s11524-008-9336-1
16. Smith, V. K. a. (2009). The Crunch Continues: Medicaid Spending, Coverage and Policy in the Midst of a Recession Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2009 and 2010 (pp. 112): Kaiser Commission on Medicaid and the Uninsured.
17. Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care, 43(6), 521-530. doi: PubMed http://dx.doi.org/10.1097/01.mlr.0000163641.86870.af
18. University of California San Diego. (2011). Chronic Illness and Disability Payment System [SAS]. Retrieved from http://cdps.ucsd.edu/
19. Vuong, T., Fenrick, B., Starner, J., Gunderson, B. W., & Gleason, P. (2011, 2011). Statin Waste Associated with 90-day Supplies Compared to 30-day Supplies [Poster]. Paper presented at the April 2011 Academy of Managed Care Pharmacy San Francisco, CA.
20. Wachino, V. (2007). The Medicaid Integrity Program: Issues and Challenges in Ensuring Program Integrity in Medicaid. Retrieved from www.kff.org/medicaid/upload/7650ES.pdf
21. Walton, S. M., Arondekar, B. V., Johnson, N. E., & Schumock, G. T. (2001). A Model for Comparing Unnecessary Costs Associated with Various Prescription Fill-Quantity Policies: Illustration Using VA Data. Journal of Managed Care Pharmacy, 7(5), 386-390.
22. White, K. G. (2010). UK interventions to control medicines wastage: a critical review. International Journal of Pharmacy Practice, 18(3), 131-140. PubMed
23. Zirker, E., Gershon, E., & Swain, K. (2010). Federal Court Says California, Despite Budget Problems, Must Comply with Disability Laws. Clearinghouse Review Journal of Poverty Law and Policy, 44(81).